Controlling the carcinoid syndrome.
作者信息
Hodgson H J
出版信息
BMJ. 1988 Nov 12;297(6658):1213-4. doi: 10.1136/bmj.297.6658.1213.
Abstract
摘要
相似文献
1
Controlling the carcinoid syndrome.控制类癌综合征。
BMJ. 1988 Nov 12;297(6658):1213-4. doi: 10.1136/bmj.297.6658.1213.
2
Management of carcinoid syndrome.类癌综合征的管理。
Postgrad Med J. 1991 Jun;67(788):506-8. doi: 10.1136/pgmj.67.788.506.
3
The carcinoid syndrome.
JAMA. 1988 Sep 16;260(11):1602-5.
4
Use of a somatostatin analogue in association with surgery and hepatic arterial embolisation in the treatment of the carcinoid syndrome.生长抑素类似物联合手术及肝动脉栓塞术治疗类癌综合征
Br J Cancer. 1987 Dec;56(6):840-2. doi: 10.1038/bjc.1987.302.
5
[Somatostatin analogs in the treatment of carcinoid syndrome: a case report and review of literature].
Pol Arch Med Wewn. 2003 Sep;110(3):997-1001.
6
[Hepatic artery embolization for treatment of the carcinoid syndrome].肝动脉栓塞术治疗类癌综合征
Z Gastroenterol. 1982 Aug;20(8):438-47.
7
[Effect of somatostatin and salmon calcitonin on carcinoid syndrome. A clinical case].[生长抑素和鲑鱼降钙素对类癌综合征的影响。1例临床病例]
Minerva Chir. 1989 May 15;44(9):1429-33.
8
Effects of somatostatin on bronchial constriction in a patient with carcinoid syndrome.生长抑素对一名类癌综合征患者支气管收缩的影响。
N Engl J Med. 1980 Aug 21;303(8):464. doi: 10.1056/NEJM198008213030823.
9
Carcinoid syndrome treated by hepatic embolization.经肝动脉栓塞治疗的类癌综合征
AJR Am J Roentgenol. 1978 Sep;131(3):511-3. doi: 10.2214/ajr.131.3.511.
10
Successful symptomatic treatment of malignant carcinoid syndrome with the somatostatin analogue SMS 201-995.
Neth J Med. 1988 Apr;32(3-4):194-8.
引用本文的文献
1
Carcinoid syndrome and serotonin: therapeutic effects of ketanserin.类癌综合征与血清素：酮色林的治疗作用
Cardiovasc Drugs Ther. 1990 Jan;4 Suppl 1:53-8. doi: 10.1007/BF00053427.
本文引用的文献
1
Studies on several possible antiserotonin compounds in a patient with the functioning carcinoid syndrome.
Ann Intern Med. 1962 Jun;56:941-5. doi: 10.7326/0003-4819-56-6-941.
2
Role of hepatic arterial embolisation in the carcinoid syndrome.肝动脉栓塞在类癌综合征中的作用。
Br Med J (Clin Res Ed). 1983 Oct 1;287(6397):932-5. doi: 10.1136/bmj.287.6397.932.
3
Treatment of the carcinoid syndrome by local removal of hepatic metastases.通过局部切除肝转移灶治疗类癌综合征。
Proc R Soc Med. 1972 May;65(5):444-5. doi: 10.1177/003591577206500505.
4
Present experiences with hepatic dearterialization in liver neoplasm.
Prog Surg. 1974;13:141-66. doi: 10.1159/000395682.
5
Carcinoid syndrome. Surgical management.类癌综合征。外科治疗
Br J Hosp Med. 1986 Mar;35(3):166, 168-70.
6
Carcinoid tumors: CT and I-131 meta-iodo-benzylguanidine scintigraphy.
Radiology. 1987 Jul;164(1):199-203. doi: 10.1148/radiology.164.1.3588904.
7
Ketanserin versus placebo in carcinoid syndrome. A clinical controlled trial.酮色林与安慰剂治疗类癌综合征的临床对照试验
Scand J Gastroenterol. 1986 Sep;21(7):816-8. doi: 10.3109/00365528609011123.
8
Carcinoid and neuroendocrine tumours of the liver.肝脏类癌和神经内分泌肿瘤
Baillieres Clin Gastroenterol. 1987 Jan;1(1):35-61. doi: 10.1016/0950-3528(87)90033-9.
9
The effects of the 5-hydroxytryptamine (5HT3) receptor antagonist ICS 205-930 in the carcinoid syndrome.
Aliment Pharmacol Ther. 1988 Apr;2(2):167-72. doi: 10.1111/j.1365-2036.1988.tb00684.x.
10
Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine.5-羟色胺功能性受体的分类与命名提案。
Neuropharmacology. 1986 Jun;25(6):563-76. doi: 10.1016/0028-3908(86)90207-8.
Zotero 插件